DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Mexitil (Mexiletine) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Mexitil (Mexiletine) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (3)

Reports by Reaction Type

Gamma-Glutamyltransferase Increased (2)Blood Alkaline Phosphatase Increased (2)Blood Lactate Dehydrogenase Increased (2)Urticaria (1)Pyrexia (1)Erythema (1)Pruritus Generalised (1)Dyspnoea Exertional (1)Human Herpes Virus 6 Serology Positive (1)Abdominal Distension (1)Cold Sweat (1)Blood Glucose Increased (1)

Possible Mexitil side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-23

Patient: male, weighing 70.0 kg (154.0 pounds)

Reactions: Pruritus, Skin Exfoliation, Urticaria, Pyrexia, Erythema, Human Herpes Virus 6 Serology Positive, Gamma-Glutamyltransferase Increased, C-Reactive Protein Increased, Oedema, Blood Glucose Increased, Blister, White Blood Cell Count Increased, Blood Alkaline Phosphatase Increased, Rash Generalised, Cytomegalovirus Test Positive, Blood Lactate Dehydrogenase Increased, Lymphocyte Stimulation Test Positive, Drug Rash With Eosinophilia and Systemic Symptoms, Pigmentation Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Tegretol
    Dosage: 200 mg, unk
    Administration route: Oral
    Indication: Nerve Injury
    Start date: 2007-08-07
    End date: 2007-08-27

Diovan
    Dosage: 20 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-07-22
    End date: 2007-08-27

Ludiomil
    Dosage: 10 mg, daily
    Administration route: Oral
    Indication: Nerve Injury
    Start date: 2007-08-15
    End date: 2007-08-27

Lipitor
    Dosage: 10 mg, daily
    Administration route: Oral
    Indication: Hyperlipidaemia
    Start date: 2007-08-26
    End date: 2007-08-27

PL Gran.
    Dosage: 3 g/ day
    Administration route: Oral
    Start date: 2007-08-28
    End date: 2007-08-29

Mexitil
    Dosage: 300 mg, daily
    Administration route: Oral
    Indication: Nerve Injury
    Start date: 2007-07-20
    End date: 2007-08-27

PL Gran.
    Dosage: 3 mg
    Administration route: Oral
    Indication: Nasopharyngitis
    Start date: 2007-08-22
    End date: 2007-08-24

Metformin HCL
    Dosage: 500 mg, daily
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2007-08-10
    End date: 2007-08-27

Other drugs received by patient: Humalog; Humacart-N; Zantac



Possible Mexitil side effects in male

Reported by a physician from Japan on 2011-10-21

Patient: male

Reactions: Hepatic Function Abnormal, Hyperkalaemia, Flatulence, Orthostatic Hypotension, Hypokalaemia, Chest Pain, Abdominal Distension, Blood Creatinine Increased, Decreased Appetite, Vomiting, Blood Urea Increased, Chronic Myeloid Leukaemia Transformation, Hypoaesthesia, Ileus Paralytic, Renal Failure, Renal Impairment, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Diflucan
    Dosage: 200 mg, daily
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2010-04-24
    End date: 2010-05-06

Tasigna
    Dosage: 800 mg, daily
    Administration route: Oral
    Start date: 2010-04-02
    End date: 2011-04-12

Oncovin
    Start date: 2010-04-02
    End date: 2010-04-15

Sulfamethoxazole
    Dosage: 1 df, unk
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2009-08-07
    End date: 2009-10-13

Tasigna
    Dosage: 600 mg, daily
    Administration route: Oral
    Start date: 2010-02-17
    End date: 2011-04-01

Oxycontin
    Dosage: 15 mg, unk
    Administration route: Oral
    Start date: 2009-08-07
    End date: 2011-04-11

Acetaminophen
    Dosage: 4 df, unk
    Start date: 2009-08-19
    End date: 2010-04-09

Prednisolone
    Dosage: 60 mg, unk
    Start date: 2009-08-07
    End date: 2009-08-12

Tasigna
    Dosage: 800 mg daily
    Administration route: Oral
    Indication: Chronic Myeloid Leukaemia
    Start date: 2009-08-07
    End date: 2009-08-19

Mexitil
    Dosage: 300 mg, daily
    Administration route: Oral
    Start date: 2010-04-09
    End date: 2010-05-06

Anafranil
    Dosage: 35 mg daily
    Administration route: Oral
    Start date: 2009-08-26
    End date: 2009-08-30

Acetaminophen
    Dosage: 6 df, unk
    Administration route: Oral
    Start date: 2010-04-15
    End date: 2010-05-06

Tasigna
    Dosage: 400 mg daily
    Administration route: Oral
    Start date: 2009-08-24
    End date: 2010-02-16

Sulfamethoxazole
    Dosage: 1 df, unk
    Administration route: Oral
    Start date: 2010-04-17
    End date: 2010-05-06

Prednisolone
    Dosage: 50 mg, unk
    Start date: 2009-08-13
    End date: 2009-08-13

Other drugs received by patient: Lasix; Carbocain; Allopurinol; Lulicon; Laxoberon; Meropenem; Mentax; Candesartan Cilexetil; Magnesium Sulfate; Ropivacaine Hydrochloride; Decadron; Aldomet; Kytril; Prochlorperazine; Oxinorm; Atarax; Famotidine; Magnesium Sulfate; Pydoxal; Pursennid; Magnesium Sulfate; Isoniazid; Leunase; Decadron; Norvasc; Doxorubicin Hydrochloride



Possible Mexitil side effects in 60 year old male

Reported by a physician from Japan on 2011-07-15

Patient: 60 year old male, weighing 89.0 kg (195.8 pounds)

Reactions: Back Pain, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Liver Disorder, Pruritus Generalised, Malaise, Dyspnoea Exertional, Gamma-Glutamyltransferase Increased, Aspartate Aminotransferase Increased, Cold Sweat, Cough

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Warfarin Sodium
    Dosage: 4 mg (1 mg,4 in 1 d),oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-05-11
    End date: 2011-05-31

Mexitil
    Dosage: 50mg x 6t x 3 (50 mg),oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-05-11
    End date: 2011-06-03

Amlodipine Besylate
    Dosage: 5 mg (5 mg,1 in 1 d),oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-05-11
    End date: 2011-06-03

Diovan
    Dosage: 160 mg (80 mg,2 in 1 d),oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-05-11
    End date: 2011-06-03

Bisoprolol Fumarate
    Dosage: 5 mg (2.5 mg,2 in 1 d),oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-06-27
    End date: 2011-06-03

Mecobalamine (Becobalamin)
    Dosage: 550ug x 3t x 3 (500 mcg),oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-03
    End date: 2011-06-03

Epinastine Hydrochloride (Aleroff)
    Dosage: (20 mg,1 in 1 d),oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-04-14
    End date: 2011-06-03

Doxazosin Mesylate
    Dosage: 4 mg (2 mg,2 in 1 d),oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-07-15
    End date: 2011-06-03

Lansoprazole
    Dosage: 15 mg (15 mg,1 in 1 d),oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-05-11
    End date: 2011-06-03

Pirmenol Hydrochloride / Hydrate (Pimenol)
    Dosage: 50mg x 2capsules x 2 (50 mg),oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-05-11
    End date: 2011-06-03

Mosapride Citrate / Hydrate (Gasmotin)
    Dosage: 5mg x 3t x 3 (5 mg),oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-12-02
    End date: 2011-06-03

Magnesium Oxide (Magmitt)
    Dosage: 250mg x 3t x 3 (250 mg),oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-07-04
    End date: 2011-05-31

Sairei-TO
    Dosage: 8.1mg x 2t x 2 (8.1 mg),oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-08-05
    End date: 2011-05-30

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012